Peptech

Peptech Limited used to be an Australian biotechnology company listed on the Australian Stock Exchange (ASX). Peptech described its operations as "...an ASX-listed Australian biotechnology company dedicated to developing and providing antibody and peptide-based human therapeutic products for the treatment of diseases in the areas of cancer and inflammation and products for fertility control in animals." The company changed its name to Arana Therapeutics in November 2007 and was subject of a successful takeover bid by Cephalon at the end of 2009.

See also


This article is issued from Wikipedia - version of the 11/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.